DHS Biodetection Improvement Act
Click any stage to learn more about the legislative process.
Would require the Department of Homeland Security to assess its use of Department of Energy national laboratories for biodetection research and submit a strategy to Congress for improving that coordination within 180 days of enactment.
What this bill would do
What it would do
The bill would direct the Secretary of Homeland Security to conduct an assessment of how DHS has used Department of Energy national laboratories and sites for research and development related to DHS missions. Within 180 days of enactment, the Secretary would be required to submit that assessment to the relevant House and Senate committees, along with a strategy for future biodetection research and development conducted in coordination with those DOE labs.
The strategy would need to cover four areas: identifying biodetection technologies that meet DHS mission needs; developing an acquisition and procurement plan to deploy those technologies to existing BioWatch jurisdictions; conducting periodic external evaluations to find gaps and failure points; and assisting federal, state, local, tribal, and private-sector partners in defining requirements for future environmental biodetection programs. The bill would also require a follow-up progress report to Congress within one year of enactment. It would not appropriate any funds or itself authorize any new program.
Key provisions
- 1Would require DHS to assess its historical use of Department of Energy national laboratories and sites for research and development related to DHS missions.
- 2Would require the Secretary to submit, within 180 days, a biodetection R&D strategy to Congress covering technology identification, procurement planning, external evaluations, and partnership with federal, state, local, tribal, and private-sector entities.
- 3Would require the strategy to include an acquisition and procurement plan for deploying identified biodetection technologies to existing BioWatch jurisdictions.
- 4Would require periodic external evaluations of biodetection technologies to identify gaps and failure points, with contingency plans if technologies underperform.
- 5Would require a follow-up report to Congress within one year of enactment updating the assessment and strategy, including challenges to implementation.
Who would be affected
The Department of Homeland Security and its Countering Weapons of Mass Destruction Office, which would carry out the assessment and strategy; Department of Energy national laboratories, which would be evaluated as research partners; and state, local, and tribal governments participating in BioWatch jurisdictions, which could ultimately receive improved biodetection technologies under any resulting procurement plan.
Why it matters
If the strategy leads to updated procurement of biodetection technology, BioWatch jurisdictions — cities and regions that rely on environmental sensors to detect airborne biological threats — could receive more capable equipment. For now, the bill's direct effect is limited to requiring a planning document; it does not itself fund or mandate any new technology deployment.
What would change
Changes to existing law
Amends Homeland Security Act of 2002, 6 U.S.C. § 189 (Sec. 2(a))
Directs DHS to conduct the assessment and strategy in accordance with section 309, aligning new reporting requirements with existing laboratory cooperation authority.
Agencies directed to act
Effective dates
- Deadline for DHS to submit biodetection strategy and assessment to Congress
- Deadline for DHS to submit follow-up update report to Congress
How implementation would work
The Secretary of Homeland Security would have 180 days to submit an assessment and strategy to the House Committee on Homeland Security and the Senate Committee on Homeland Security and Governmental Affairs. The strategy must address technology identification, an acquisition and procurement plan consistent with the Federal Acquisition Regulation, periodic external evaluations of identified technologies, and partnership with governments and the private sector on program requirements. A follow-up update reporting on implementation challenges is due within one year of enactment. No rulemaking is required; the bill is primarily a reporting and planning mandate.
Legislative status & sources
Latest action
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Official CRS summary
Show the CRS summaryHide the CRS summary
This bill directs the Department of Homeland Security (DHS) to assess how it has utilized Department of Energy national laboratories and sites for research and development in carrying out DHS missions and to report to Congress a strategy for how DHS will conduct biodetection research and development in coordination with such laboratories and sites.
Legislative subjects
Advanced technology and technological innovations; Chemical and biological weapons; Congressional oversight; Drug safety, medical device, and laboratory regulation; Government Operations and Politics; Infectious and parasitic diseases; Public contracts and procurement; Research and development